Stop Meth Labs and Enhance Patient Access Act of 2015

H.R. 3968 · 114th Congress · Nov 5, 2015 · Lineage

A BILL

To amend the Controlled Substances Act to allow the Attorney General to exempt a product from certain requirements if the Attorney General determines that it is not practical by processes known to be employed by clandestine laboratory operators to use the product in the illicit manufacture of methamphetamine.

Section 1 Short title

This Act may be cited as the “Stop Meth Labs and Enhance Patient Access Act of 2015”.

Sec. 2 Exemption for products if it is not practical by processes known to be employed by clandestine laboratory operators to use the products in the illicit manufacture of methamphetamine

Section 310(e)(3) of the Controlled Substances Act (21 U.S.C. 830(e)(3)) is amended by striking “if the Attorney General determines that the product cannot be used in the illicit manufacture of methamphetamine” and inserting “if the Attorney General determines that it is not practical by processes known to be employed by clandestine laboratory operators to use the product in the illicit manufacture of methamphetamine”.

Lineage

Nov 5, 2015viewing Introduced in House Mr. Guinta introduced the following bill; which was referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned

Stop Meth Labs and Enhance Patient Access Act of 2015

Section 1 Short title

Sec. 2 Exemption for products if it is not practical by processes known to be employed by clandestine laboratory operators to use the products in the illicit manufacture of methamphetamine

Cite this provision

Incoming references